Edwards Lifesciences Corp

EW.US
Healthcare · Medical Devices
83.68
+0.64 (+0.77%)
USD · NYSE

Company Information

Company Name
Edwards Lifesciences Corp
Sector
Healthcare
Industry
Medical Devices
Exchange
NYSE
ISIN: US28176E1082
CIK: 0001099800
CUSIP: 28176E108
Currency: USD
Full Time Employees: 16,000
Phone: 949 250 2500
Fiscal Year End: December
IPO Date: Mar 27, 2000
Description:

Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL and EVOQUE brands. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS brand name; INSPIRIS RESILIA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valve conduit for complex combined procedures; and MITRIS RESILIA valve. It distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.

Address:

One Edwards Way, Irvine, CA, United States, 92614

People

Directors & Officers

Name Title Year Born
Mr. Bernard J. Zovighian CEO & Director 1968
Mr. Donald E. Bobo Jr. Corporate Vice President of Strategy & Corporate Development 1962
Mr. Daveen Chopra Corporate Vice President of Transcatheter Mitral & Tricuspid Therapies 1979
Ms. Annette Maria Bruls Corporate Vice President of EMEA, Canada, & Latin America 1971
Ms. Theodora Mistras Corporate VP & CFO 1982
Mr. Joseph Nuzzolese Corporate Vice President of Global Operations & Quality NA
Mr. Andrew M. Dahl Principal Accounting Officer, Senior VP & Corporate Controller 1978
Dr. Todd Brinton FACC, M.D. Corporate VP of Advanced Innovation & Technology and Chief Scientific Officer NA
Mr. Snehashish Sarkar Senior VP and Chief Information & Digital Officer 1975
Mr. Mark D. Peterson Corporate VP & General Counsel 1963

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Apr 09, 2026 Scott B Ullem N/A Sale 13.00K $80.04 $1.04M
Apr 06, 2026 Daniel J Lippis N/A Sale 1.02K $80.98 $82.52K
Apr 02, 2026 Donald E Bobo Jr N/A Sale 22.68K $80.16 $1.82M
Mar 30, 2026 Ro Khanna N/A Sale N/A $79.52 N/A
Mar 23, 2026 Ro Khanna N/A Purchase N/A $81.95 N/A
Mar 11, 2026 Daniel J Lippis N/A Sale 1.02K $85.38 $87.00K
Mar 11, 2026 Scott B Ullem N/A Sale 13.00K $84.92 $1.10M
Mar 02, 2026 Donald E Bobo Jr N/A Sale 11.34K $85.93 $974.45K
Feb 25, 2026 Donald E Bobo Jr N/A Sale 24.00K $83.84 $2.01M
Feb 05, 2026 Ro Khanna N/A Sale N/A $78.06 N/A
Jan 09, 2026 Daniel J Lippis N/A Sale 1.02K $85.70 $87.33K
Jan 06, 2026 Donald E Bobo Jr N/A Sale 11.34K $85.66 $971.38K
Dec 12, 2025 Daniel J Lippis N/A Sale 1.02K $84.03 $85.63K
Dec 12, 2025 Donald E Bobo Jr N/A Sale 11.39K $83.76 $953.69K
Dec 10, 2025 Donald E Bobo Jr N/A Sale 11.34K $83.83 $950.63K
Dec 09, 2025 Scott B Ullem N/A Sale 7.70K $84.47 $650.42K
Nov 19, 2025 Josh Gottheimer N/A Sale N/A $85.85 N/A
Nov 10, 2025 Daniel J Lippis N/A Sale 1.02K $82.55 $84.20K
Nov 10, 2025 Scott B Ullem N/A Sale 13.00K $83.08 $1.08M
Oct 07, 2025 Ro Khanna N/A Sale N/A $76.70 N/A

Shareholders

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
Vanguard Group Inc 70.08M Dec 31, 2025 12.17% $0.09 -0.40%
BlackRock Inc 52.59M Mar 31, 2026 9.13% $0.07 0.25%
Vanguard Capital Management, LLC 37.73M Mar 31, 2026 6.55% $0.07 0.00%
Vanguard Portfolio Management, LLC 26.41M Mar 31, 2026 4.59% $0.11 0.00%
State Street Corp 26.30M Mar 31, 2026 4.57% $0.07 1.17%
Wellington Management Company LLP 22.01M Mar 31, 2026 3.82% $0.33 1.00%
JPMorgan Chase & Co 21.74M Mar 31, 2026 3.78% $0.11 -16.45%
Bank of New York Mellon Corp 16.74M Mar 31, 2026 2.91% $0.25 -4.32%
FMR Inc 14.50M Mar 31, 2026 2.52% $0.06 -12.54%
Geode Capital Management, LLC 13.13M Mar 31, 2026 2.28% $0.07 2.73%
Jennison Associates LLC 13.07M Mar 31, 2026 2.27% $0.72 -5.18%
DZ BANK AG Deutsche Zentral-Genossenschaftsbank Frankfurt am Main 12.81M Mar 31, 2026 2.23% $0.91 65.70%
Ninety One UK Limited 12.40M Mar 31, 2026 2.15% $2.30 60.26%
NORGES BANK 9.43M Dec 31, 2025 1.64% $0.09 26.98%
Morgan Stanley - Brokerage Accounts 7.06M Mar 31, 2026 1.23% $0.03 -3.46%
Brown Advisory Holdings Inc 7.03M Mar 31, 2026 1.22% $0.93 -4.13%
Deutsche Bank AG 6.06M Mar 31, 2026 1.05% $0.16 8.54%
Northern Trust Corp 5.82M Mar 31, 2026 1.01% $0.06 -0.95%
UBS Asset Mgmt Americas Inc 5.46M Mar 31, 2026 0.95% $0.09 1.38%
Artisan Partners Limited Partnership 5.20M Mar 31, 2026 0.90% $0.67 345.79%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Vanguard Total Stock Mkt Idx Inv 18.28M 3.18% ▼ 1.10% Jun 30, 2026
2 Vanguard 500 Index Investor 14.96M 2.60% ▼ 1.55% Jun 30, 2026
3 Vanguard Health Care Inv 14.83M 2.58% ▼ 0.97% Mar 31, 2026
4 Vanguard Mid Cap Index Institutional 12.48M 2.17% ▼ 0.98% Jun 30, 2026
5 iShares Core S&P 500 ETF 7.95M 1.38% ▲ 0.32% Jun 30, 2026
6 Fidelity 500 Index 7.43M 1.29% ▼ 0.14% May 31, 2026
7 State Street® SPDR® S&P 500® ETF 6.96M 1.21% ▼ 1.29% Jun 30, 2026
8 Vanguard Value Index Inv 5.47M 0.95% ▲ 0.94% Jun 30, 2026
9 Vanguard Mid-Cap Growth ETF 4.41M 0.77% ▲ 0.03% Jun 30, 2026
10 UniGlobal Vorsorge 4.25M 0.74% ▲ 25.26% May 31, 2026

Financial Highlights

Market Cap: $48.18B
EBITDA: $2.00B
P/E Ratio: $49.51
PEG Ratio: $2.00
Book Value: $17.90
Earnings/Share: $1.69
Profit Margin: 15.43%
Operating Margin: 29.84%
ROA (TTM): 8.27%
ROE (TTM): 10.46%
Revenue (TTM): $6.51B
Revenue/Share (TTM): $11.22
Earnings Growth (YOY): -25.40%
Revenue Growth (YOY): 13.60%

Valuation Metrics

Enterprise Value: $44.85B
Trailing P/E: 49.51
Forward P/E: 27.70

Shares Statistics

Shares Outstanding: 575.80M
Shares Float: 573.98M
% Insiders: 18.40%
% Institutions: 9,432.20%
Short % Float: 2.24%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Income Statement Waterfall

Open full waterfall
Line Item
Step Type
Value
Revenue
adjust
$6.07B
Cost of Goods Sold
adjust
$-1.33B
Gross Profit
subtotal
$4.74B
SG&A
adjust
$-2.09B
R&D
adjust
$-1.08B
Operating Income
subtotal
$1.64B
Other / Non-Operating Items
adjust
$-562.70M
Net Income
subtotal
$1.07B

Earnings Per Share (EPS) History

Financial Ratios

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about EW.US!